Lexel – Nestor Rava, CEO – Argentina
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Promedon is an international company, leader in the research, development, production and distribution of innovative medical technology, present in more than 60 countries around the world.
Since 1985, the company has contributed to the progress of medicine through the research,manufacturing and marketing of urology, urogynecology and coloproctology products with the aim of improving patients quality of life. Furthermore, leads the industry in the distribution of arthroscopy and arthroplasty solutions in Argentina and Chile, and is an important player in the distribution of spine,neurosurgery and reconstructive surgery solutions in the Argentine, Brazilian and Chilean markets.
Promedon is headquartered in the city of Cordoba, Argentina. The Promedon headquarters building houses the Corporate Management, the Research and Development Center, the Manufacture and Production Area, as well as the Corporate Administration and Finance, Marketing, Sales, Logistics and Operations, and Human Resources offices.
Promedon has commercial offices located in the most important cities of Argentina, Brazil, Chile and Mexico, and a Warehouse in the Netherlands to provide the European market. The upcoming opening of Promedon Germany during the last quarter of 2014 marks the company landing in the most important market in Europe.
Contact Details
Promedon
Av. Gral Manuel Savio s / n Lote 3 – Manzana 3
Industrial Park Ferreyra (X5925XAD)
Córdoba
Córdoba – AR
Tel .: +54 (351) 4502100
Tel .: +54 (351) 4502130
promedon@promedon.com
internationalsales@promedon.com
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
“In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes about the capacity of…
The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a strong branded generics market…
See our Cookie Privacy Policy Here
